Statera BioPharma (STU:7CB) FCF Yield %: -10.03 (As of Jun. 29, 2026)


What is Statera BioPharma FCF Yield %?

Statera BioPharma STU:7CB 20 FCF Yield % is -10.03 as of Jun. 29, 2026. GuruFocus rates STU:7CB with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Statera BioPharma's Trailing 12-Month Free Cash Flow is €0.00 Mil, and Market Cap is €0.01 Mil. Therefore, Statera BioPharma's FCF Yield % for today is -10.03%.

The historical rank and industry rank for Statera BioPharma's FCF Yield % or its related term are showing as below:

STU:7CB' s FCF Yield % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -10.03

STU:7CB's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -9.62 vs STU:7CB: -10.03

Statera BioPharma's FCF Margin % for the quarter that ended in Sep. 2022 was 0.00%.

Statera BioPharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Statera BioPharma FCF Yield % Related Terms

Statera BioPharma FCF Yield % Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma FCF Yield % Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
FCF Yield %
0.00 0.00 0.00

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:7CB vs NRBO, PALI, BLCM: FCF Yield % Comparison

For the Biotechnology subindustry, Statera BioPharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Statera BioPharma FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's FCF Yield % falls into.


Statera BioPharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Statera BioPharma's FCF Yield % for the fiscal year that ended in Dec. 2021 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-25.113 / 0
=N/A%

Statera BioPharma's annualized FCF Yield % for the quarter that ended in Sep. 2022 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.81 * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -10.03 mean?
Statera BioPharma (STU:7CB) has a FCF Yield % of -10.03 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Statera BioPharma and its competitors.
Is Statera BioPharma's FCF Yield % too high?
Statera BioPharma's current FCF Yield % is -10.03. Overall, Statera BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Statera BioPharma's FCF Yield % compare to NRBO and PALI?
Statera BioPharma's FCF Yield % of -10.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Statera BioPharma and its competitors. Statera BioPharma's current FCF Yield % is -10.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (STU:7CB) has a current FCF Yield % of -10.03. The current FCF Yield % is -10.03. Statera BioPharma's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Statera BioPharma (STU:7CB), the current FCF Yield % is -10.03 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.